Cognition Therapeutics, Inc. (CGTX)
0.9796
-0.01
(-1.05%)
USD |
NASDAQ |
Sep 10, 16:00
0.95
-0.03
(-3.02%)
After-Hours: 20:00
Cognition Therapeutics Net Income (Quarterly) : -3.932M for June 30, 2026
Net Income (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -3.932M |
| March 31, 2026 | -4.57M |
| December 31, 2025 | -3.343M |
| September 30, 2025 | -4.93M |
| June 30, 2025 | -6.734M |
| March 31, 2025 | -8.48M |
| December 31, 2024 | -7.842M |
| September 30, 2024 | -9.937M |
| June 30, 2024 | -7.041M |
| March 31, 2024 | -9.151M |
| December 31, 2023 | -8.141M |
| September 30, 2023 | -6.749M |
| June 30, 2023 | -4.726M |
| Date | Value |
|---|---|
| March 31, 2023 | -6.172M |
| December 31, 2022 | -5.182M |
| September 30, 2022 | -6.625M |
| June 30, 2022 | -5.752M |
| March 31, 2022 | -3.838M |
| December 31, 2021 | -7.339M |
| September 30, 2021 | -3.11M |
| June 30, 2021 | -1.49M |
| March 31, 2021 | 0.223M |
| September 30, 2020 | -1.791M |
| June 30, 2020 | -1.674M |
| March 31, 2020 | -2.506M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Zevra Therapeutics, Inc. | 8.393M |
| Bristol Myers Squibb Co. | 3.316B |
| Structure Therapeutics, Inc. | -106.33M |
| ANI Pharmaceuticals, Inc. | 23.00M |
| Corcept Therapeutics, Inc. | 42.14M |
Net Income (Quarterly) Related Metrics
| Total Expenses (Quarterly) | 3.932M |
| EPS Diluted (Quarterly) | -0.0434 |
| Enterprise Value | 59.93M |
| Earnings Yield | -19.95% |
| Normalized Earnings Yield | -19.96 |